ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

LAB vs CTKB // 10Y YIELD & FRED MACRO BETA

Standard BioTools Inc. (NASDAQ) VS. Cytek Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: LAB 1 — CTKB 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LAB VS. CTKB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC LAB CTKB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 49.90% 51.80% -1.90 CTKB /gross-margins <GO>
Return on Invested Capital (ROIC) -28.70% -12.70% -16.00 CTKB /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -1.07% — TIE /fcf-yield <GO>
Operating Margin -60.00% -20.00% -40.00 CTKB /operating-margins <GO>
Net Profit Margin -60.00% -33.00% -27.00 CTKB /net-margins <GO>
Revenue Growth (YoY) -6.20% 0.50% -6.70 CTKB /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 4.76 -4.56 CTKB /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 LAB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.8 68.7 -27.90 CTKB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $244.7M $818.9M -$574.2M CTKB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR LAB REV CTKB REV LAB GROSS % CTKB GROSS % LAB FCF CTKB FCF
FY 2025 $85.3M $201.5M 49.9% 51.8% -$82.6M -$8.8M
FY 2024 $91.0M $200.5M 49.3% 55.4% -$151.8M $21.9M
FY 2023 $106.3M $193.0M — — -$43.3M $5.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LAB // BETA —
CTKB // BETA —